More answers like this
Grok 4.5Oct 21, 2026x-ai/grok-4.5-20260708

Is the US prepared to deal with another pandemic or widespread health crisis?

No, the US is not fully prepared for another pandemic or major widespread health crisis, though it has improved in some technical areas since COVID-19. Significant gaps remain in coordination, funding sustainability, public health infrastructure, research priorities, international engagement, and state-level readiness, and recent policy shifts have weakened key defenses according to multiple expert assessments.[1][2]

Progress Made Post-COVID

After COVID-19 (which caused over 1 million US deaths), the US took steps to address some failures:

•Stockpiles and countermeasures: The Strategic National Stockpile (SNS) was substantially replenished (e.g., far higher levels of N95 respirators, gloves, gowns, and ventilators). Agencies like BARDA and ASPR advanced medical countermeasures (MCMs), with ongoing responses to threats like H5N1 bird flu (stockpiling vaccines, PPE distribution) and other outbreaks (mpox, Ebola/Marburg support).[3][4]
•Surveillance and data: Major upgrades in electronic case reporting (from under 200 healthcare facilities pre-COVID to over 45,000+) and syndromic surveillance. Wastewater monitoring and other tools expanded.[5]
•Coordination structures: Congress created the White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2022–2023 to lead cross-agency efforts. The Biden administration released roadmaps, updated biodefense strategies, and invested in global health security (e.g., Pandemic Fund contributions, vaccine sharing).[3]
•Other: Faster MCM platforms (e.g., mRNA adaptability), some laboratory “warm bases,” nurse licensure compact expansion (aiding surge staffing), and public health/emergency management accreditations in many states. GAO and others noted successes in rapid vaccine development/distribution once scaled.[6]

ASPR continues active operations for all-hazards preparedness.[7]

Persistent and Growing Gaps

Experts, GAO, bipartisan commissions, and reports like Trust for America’s Health (TFAH) “Ready or Not” series highlight unfinished business and new risks:

•Unimplemented lessons: As of mid-2024, GAO had made hundreds of COVID-related recommendations (over 400 total; ~220 still open then), covering HHS leadership/coordination, supply chains, testing strategies, data sharing, planning, and more. Many high-risk areas (e.g., HHS emergency leadership) persist.[6][6]
•Funding and infrastructure: Boom-bust cycles continue. Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) faces multi-billion-dollar shortfalls. State public health funding has declined in multiple states; workforce shortages and lab surge capacity vary. TFAH’s 2025/2026 reports place only about 20–21 states (+DC) in the high-performance tier for emergency preparedness (indicators include funding, vaccination rates, hospital safety, labs, paid leave, water systems, etc.); many are middle or low. Flu vaccination rates lag goals.[8][9][10]
•Coordination, trust, and equity: Federal-state tensions, ambiguous authorities, healthcare access disparities, and eroded public trust (exacerbated by misinformation) hinder response. Supply chains remain vulnerable; hospital surge capacity and chronic disease burdens weaken resilience.[11]
•Bipartisan Commission on Biodefense (2024 National Blueprint): Emphasized growing biological threats (natural, accidental, deliberate) and the need for stronger leadership, intelligence, S&T, detection, and response—calling for immediate action.[12]

COVID exposed weaknesses despite the US ranking highly on pre-2020 Global Health Security Index metrics; outcomes were poor relative to peers in excess deaths and other measures.[11]

Recent Developments (2025 onward) Have Raised Concerns

Multiple sources (including expert commentary in Science, Bloomberg, The Scientist, and others) report that second-term Trump administration policies—under HHS Secretary RFK Jr. and others—have dismantled or sidelined elements of preparedness:

•OPPR was largely emptied/understaffed for extended periods (staff departures; minimal or no leadership at times), though limited restaffing has been noted.[13][14]
•NIAID/NIH strategic shifts de-emphasized biodefense, emerging infectious diseases, and pandemic preparedness; Centers for Research in Emerging Infectious Diseases closed; related funding redirected or cut. CDC faced workforce reductions and discontinuation of numerous databases (many vaccine/respiratory-focused).[15][15][16]
•Restrictions on certain high-risk pathogen research (e.g., gain-of-function), reduced global health security engagement (WHO withdrawal completed; funding cuts/suspensions for related programs like CEPI/Pandemic Fund elements; USAID impacts), and concerns over mRNA research.[17][18]
•Experts warn these raise the risk of worse outcomes in a future outbreak, with rebuilding taking years. ASPR and some core functions continue, but overall capacity for early detection, innovation, and coordinated response is viewed as diminished.[19]

Global context is also challenging: pandemic risk is rising (climate, spillover, etc.), while international reforms lag.[20]

Bottom Line

The US has stronger stockpiles, better data tools, and advanced MCM platforms than in early 2020, plus experience from COVID and ongoing responses to avian flu and other threats. However, it is not adequately prepared for a severe, novel pandemic due to incomplete implementation of lessons, uneven state readiness, fragile funding/workforce, coordination shortfalls, declining public trust, and recent erosions in research, leadership structures, and global partnerships.[21][22]

Preparedness is dynamic—a future crisis’s impact would depend on the pathogen, timing, leadership decisions, and public compliance. Sustained, bipartisan investment in core public health, resilient supply chains, surveillance, R&D (with appropriate biosafety), surge capacity, equity, and trust-building would close gaps. Without it, the pattern of “forget then scramble” risks repeating at high human and economic cost. Assessments from GAO, TFAH, biodefense commissions, and independent experts consistently urge stronger, more consistent action.

Citations (22)

  1. 1stimson.orgNonprofits and think tanks
    https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/

    Backs: “Significant gaps remain in coordination, funding sustainability, public health infrastructure, research priorities, international engagement, and state-level readiness, and recent policy shifts have weakened key defenses according to multiple expert assessments.”

  2. 2bloomberg.comNews and mediaquality 0.84
    https://www.bloomberg.com/news/articles/2026-06-11/is-the-us-prepared-for-the-next-pandemic-how-trump-s-policies-weakened-defenses

    Backs: “Significant gaps remain in coordination, funding sustainability, public health infrastructure, research priorities, international engagement, and state-level readiness, and recent policy shifts have weakened key defenses according to multiple expert assessments.”

  3. 3archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/

    Backs: “Agencies like BARDA and ASPR advanced medical countermeasures (MCMs), with ongoing responses to threats like H5N1 bird flu (stockpiling vaccines, PPE distribution) and other outbreaks (mpox, Ebola/Marburg support).”

  4. 4aspr.govGovernment
    https://www.aspr.gov/news-updates/blog/2025-12/stand-ready-move-fast-save-lives

    Backs: “Agencies like BARDA and ASPR advanced medical countermeasures (MCMs), with ongoing responses to threats like H5N1 bird flu (stockpiling vaccines, PPE distribution) and other outbreaks (mpox, Ebola/Marburg support).”

  5. 5cdc.govGovernment
    https://www.cdc.gov/washington/testimony/2024/t20241114.htm

    Backs: “Major upgrades in electronic case reporting (from under 200 healthcare facilities pre-COVID to over 45,000+) and syndromic surveillance. Wastewater monitoring and other tools expanded.”

  6. 6gao.govGovernment
    https://www.gao.gov/products/gao-24-107175

    Backs: “GAO and others noted successes in rapid vaccine development/distribution once scaled.”

  7. 7aspr.govGovernment
    https://www.aspr.gov/

    Backs: “ASPR continues active operations for all-hazards preparedness.”

  8. 8tfah.orgNonprofits and think tanks
    https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/

    Backs: “TFAH’s 2025/2026 reports place only about 20–21 states (+DC) in the high-performance tier for emergency preparedness (indicators include funding, vaccination rates, hospital safety, labs, paid leave, water systems, etc.); many are middle or low. Flu vaccination rates lag goals.”

  9. 9tfah.orgNonprofits and think tanks
    https://www.tfah.org/report-details/ready-or-not-2026/

    Backs: “TFAH’s 2025/2026 reports place only about 20–21 states (+DC) in the high-performance tier for emergency preparedness (indicators include funding, vaccination rates, hospital safety, labs, paid leave, water systems, etc.); many are middle or low. Flu vaccination rates lag goals.”

  10. 10tfah.orgNonprofits and think tanks
    https://www.tfah.org/article/preparedness-for-public-health-emergencies-at-risk-amid-federal-funding-and-workforce-instability/

    Backs: “TFAH’s 2025/2026 reports place only about 20–21 states (+DC) in the high-performance tier for emergency preparedness (indicators include funding, vaccination rates, hospital safety, labs, paid leave, water systems, etc.); many are middle or low. Flu vaccination rates lag goals.”

  11. 11nejm.orgAcademic
    https://www.nejm.org/doi/full/10.1056/NEJMp2406427

    Backs: “Supply chains remain vulnerable; hospital surge capacity and chronic disease burdens weaken resilience.”

  12. 12biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/

    Backs: “Emphasized growing biological threats (natural, accidental, deliberate) and the need for stronger leadership, intelligence, S&T, detection, and response—calling for immediate action.”

  13. 13notus.orgNot yet classified
    https://www.notus.org/health-science/white-house-pandemic-preparedness

    Backs: “OPPR was largely emptied/understaffed for extended periods (staff departures; minimal or no leadership at times), though limited restaffing has been noted.”

  14. 14cnn.comNews and mediaquality 0.66
    https://www.cnn.com/2025/03/17/health/pandemic-preparedness-office-trump-bird-flu

    Backs: “OPPR was largely emptied/understaffed for extended periods (staff departures; minimal or no leadership at times), though limited restaffing has been noted.”

  15. 15the-scientist.comNot yet classified
    https://www.the-scientist.com/niaid-moves-away-from-biodefense-experts-are-worried-75109

    Backs: “CDC faced workforce reductions and discontinuation of numerous databases (many vaccine/respiratory-focused).”

  16. 16infectioncontroltoday.comNot yet classified
    https://www.infectioncontroltoday.com/view/opinion-us-biodefense-policy-scrutiny-nih-cdc-pandemic-preparedness-programs-face-cuts

    Backs: “CDC faced workforce reductions and discontinuation of numerous databases (many vaccine/respiratory-focused).”

  17. 17infectioncontroltoday.comNot yet classified
    https://www.infectioncontroltoday.com/view/can-we-prepare-next-pandemic-without-studying-dangerous-pathogens-experts-question-new-gain-function-policy

    Backs: “Restrictions on certain high-risk pathogen research (e.g., gain-of-function), reduced global health security engagement (WHO withdrawal completed; funding cuts/suspensions for related programs like CEPI/Pandemic Fund elements; USAID impacts), and concerns over mRNA research.”

  18. 18kff.orgNonprofits and think tanks
    https://files.kff.org/attachment/fact-sheet-the-trump-administrations-foreign-aid-review-status-of-global-health-security-pandemic-preparedness.pdf

    Backs: “Restrictions on certain high-risk pathogen research (e.g., gain-of-function), reduced global health security engagement (WHO withdrawal completed; funding cuts/suspensions for related programs like CEPI/Pandemic Fund elements; USAID impacts), and concerns over mRNA research.”

  19. 19science.orgAcademic
    https://science.org/content/article/trump-administration-dismantling-efforts-fight-next-pandemic

    Backs: “ASPR and some core functions continue, but overall capacity for early detection, innovation, and coordinated response is viewed as diminished.”

  20. 20healthpolicy-watch.newsNews and media
    https://healthpolicy-watch.news/pandemic-risk-global-monitoring-board/

    Backs: “Global context is also challenging: pandemic risk is rising (climate, spillover, etc.), while international reforms lag.”

  21. 21thebulletin.orgNews and mediaquality 0.82
    https://thebulletin.org/premium/2025-12/the-united-states-isnt-prepared-for-another-pandemic-heres-what-should-happen/

    Backs: “However, it is not adequately prepared for a severe, novel pandemic due to incomplete implementation of lessons, uneven state readiness, fragile funding/workforce, coordination shortfalls, declining public trust, and recent erosions in research, leadership structures, and global partnerships.”

  22. 22bmj.comAcademic
    https://www.bmj.com/content/384/bmj.q332

    Backs: “However, it is not adequately prepared for a severe, novel pandemic due to incomplete implementation of lessons, uneven state readiness, fragile funding/workforce, coordination shortfalls, declining public trust, and recent erosions in research, leadership structures, and global partnerships.”